Table 1 Distribution of C6 rat glioma cells in different phases of the cell cycle under treatment for 24 h with 4-thiazolidinone derivatives Les-3288 and Les-3833 in free form and in complex with polymeric nanocarrier (PNC)

3.52 ± 0.67

75.06 ± 0.57

11.61 ± 0.22

10.82 ± 1.21

3.30 ± 0.44

76.03 ± 0.52

13.33 ± 0.41

8.81 ± 0.92

5.78 ± 0.51

61.30 ± 0.50^***

12.07 ± 0.12

16.06 ± 0.18

2.81 ± 0.45

75.99 ± 0.06

12.01 ± 0.43

10.32 ± 1.10

5.99 ± 0.54^*

63.33 ± 0.67^***

16.09 ± 0.12^***

15.19 ± 0.43^***

3.27 ± 0.31

73.54 ± 0.39

12.48 ± 1.20

11.44 ± 0.40

24.89 ± 1.49^●●●

47.65 ± 0.34^●●●

9.77 ± 0.53^●●●

16.45 ± 0.16

3.06 ± 0.45

72.99 ± 0.84^*

12.92 ± 1.11

12.07 ± 0.31

2.88 ± 0.67

72.53 ± 1.09^**

13.23 ± 0.56

12.64 ± 0.41

9.11 ± 0.53^###

54.86 ± 0.57^###

17.40 ± 0.61

19.55 ± 1.41^#

18.69 ± 1.71^§§§

53.42 ± 0.21^§§§

12.30 ± 0.55

15.32 ± 1.91